Anika Therapeutics Inc
Anika Therapeutics Inc logo
ANIK

Anika Therapeutics Inc (ANIK)

$30.821.22%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$30.39
Day's Range
$31.16
$19.95
52-Week Range
$41.19
1 month return4.4%
3 month return32.84%
1 year return23.41%
5 year return41.84%

Company Information

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Anika Therapeutics partners with clinicians to understand what they need most to treat their patients and develos minimally invasive products that restore active living for people around the world. The company ise committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe.
OrganizationAnika Therapeutics Inc
Employees297
CEODr. Cheryl Renee Blanchard Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 4 analysts ratings

Buy
75%
Buy
25%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for Anika Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 14.63%

Current

$30.82

Target

$35.33

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
3
6
6
Hold
1
2
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
444.9M
Book Value
$19.51
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.12
PEG Ratio
3.19
Wall Street Target Price
35.33

Valuation

Trailing PE0.0
Forward PE78.74
Price/Book (mrq)
1.62
Enterprise Value
404.4M
Enterprise Value/Revenue
2.65
Enterprise Value/Ebitda
-62.41

Technicals

Beta
0.98
50 Day MA
27.46
200 Day MA
24.69

Institutional Holdings

BlackRock Inc

16.83%

Trigran Investments Inc

10.21%

Vanguard Group Inc

6.76%

Dimensional Fund Advisors, Inc.

6.43%

State Street Corporation

6.29%

Morgan Stanley - Brokerage Accounts

4.86%

Discover more

Frequently Asked Questions

What is Anika Therapeutics Inc share price today?

Can Indians buy Anika Therapeutics Inc shares?

How can I buy Anika Therapeutics Inc shares from India?

Can Fractional shares of Anika Therapeutics Inc be purchased?

What are the documents required to start investing in Anika Therapeutics Inc stocks?

What are today’s High and Low prices of Anika Therapeutics Inc?

What are today’s traded volumes of Anika Therapeutics Inc?

What is today’s market capitalisation of Anika Therapeutics Inc?

What is the 52 Week High and Low Range of Anika Therapeutics Inc?

How much percentage Anika Therapeutics Inc is down from its 52 Week High?

How much percentage Anika Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Anika Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Anika Therapeutics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*